Status:
COMPLETED
High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer
Lead Sponsor:
Shandong Provincial Hospital
Conditions:
Bladder Cancer
Eligibility:
All Genders
20-88 years
Brief Summary
A retrospective study was designed in this study. The surgeon performed high-power green-light laser endoscopic submucosal dissection (HPL-ESD) for the treatment of primary non-muscle-invasive bladder...
Detailed Description
Background: In recent years, endoscopic laser surgery has been introduced to the treatment of NMIBC. Various types of laser (holmium laser, thulium laser and green-light laser) have been examined in t...
Eligibility Criteria
Inclusion
- Patients with non-muscle invasive bladder cancer who received high-power green laser submucosal resection of bladder tumor
Exclusion
- Patients with muscle invasive bladder cancer
- Patients with recurrent bladder cancer
- Patients with benign bladder tumor
Key Trial Info
Start Date :
May 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05290623
Start Date
May 1 2018
End Date
March 18 2022
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China, 250000